Sermorelin is not a controlled substance. It does not appear on any schedule of the Controlled Substances Act, and the DEA does not regulate it alongside drugs like opioids, stimulants, or anabolic steroids. However, sermorelin still requires a prescription, and its availability in the United States is more complicated than its legal classification might suggest.
Why Sermorelin Is Not Scheduled
The Controlled Substances Act places drugs into one of five schedules based on their potential for abuse, accepted medical use, and risk of dependence. Sermorelin doesn’t meet the criteria for any of these schedules. It’s a synthetic version of a hormone your pituitary gland already produces naturally, called growth hormone-releasing hormone (GHRH). Rather than directly supplying growth hormone, sermorelin signals the pituitary to release its own growth hormone in natural pulses. This pulsatile release pattern produces fewer side effects compared to the steady increase that comes from injecting growth hormone directly.
That distinction matters legally. Human growth hormone (HGH) itself is tightly regulated under federal law. Distributing HGH for non-approved purposes, like anti-aging or bodybuilding, is a federal crime. Sermorelin doesn’t carry those same restrictions because it works indirectly, stimulating your body’s own production rather than replacing the hormone outright. There’s also no established pattern of physical dependence or addiction with sermorelin use.
It’s Not Controlled, but It’s Not Easily Available
Sermorelin was originally FDA-approved in 1997 under the brand name Geref for treating growth failure in children. Its manufacturer pulled it from the market in 2006, not because of safety concerns, but because higher doses were needed to be effective and better alternatives existed. The FDA now lists sermorelin as a “discontinued drug product.”
This means you can’t walk into a regular pharmacy and fill a sermorelin prescription the way you would for most medications. The only current way to obtain sermorelin in the U.S. is through a compounding pharmacy, which prepares individualized medications to order. Compounded drugs are not FDA-approved, so the FDA does not verify their safety, effectiveness, or quality the way it does for standard medications.
Compounding Rules Are Tightening
The regulatory landscape for compounded sermorelin has been shifting. There are two types of compounding pharmacies under federal law. Section 503A pharmacies fill individual prescriptions, while 503B outsourcing facilities can produce larger batches. Recent FDA guidance restricts what each type can compound. Outsourcing facilities can only compound drugs on specific approved lists or FDA-approved drugs currently in shortage. Since sermorelin is not on the 503B approved bulk drugs list, outsourcing facilities face restrictions on producing it.
For 503A pharmacies, the situation is also evolving. Under updated FDA guidance, these pharmacies cannot compound substances that lack a U.S. Pharmacopeia monograph unless those substances have been placed on a specific review list. Peptides like sermorelin fall into a gray area that regulators are actively evaluating. If you’re currently using sermorelin or considering it, availability could change depending on how these regulatory reviews play out.
Prescription Requirements
Even though sermorelin isn’t a controlled substance, you still need a valid prescription from a licensed provider. Because it’s not scheduled, prescribers don’t need a special DEA registration to write for it, and pharmacies don’t need to follow the additional record-keeping and security protocols required for controlled substances. A standard prescription is sufficient.
In practice, most people obtain sermorelin through telemedicine clinics or anti-aging practices that specialize in hormone optimization. The prescribing provider typically orders blood work to assess your growth hormone levels before writing a prescription, and the medication is then prepared and shipped by a compounding pharmacy.
Traveling With Sermorelin
Since sermorelin is an injectable medication, you may wonder about carrying it through airport security or across state lines. The TSA allows medically necessary liquids and injectables in reasonable quantities for your trip. You should declare injectable medications at the checkpoint for inspection. The TSA recommends labeling your medications but does not require it. You won’t need the kind of documentation sometimes required for controlled substances, like proof of a valid prescription on a DEA form, though keeping your prescription label visible can make the screening process smoother.
State laws on compounded medications can vary, so if you’re traveling between states, the legality of possessing your specific compounded formulation could depend on the regulations where you’re headed. A valid prescription from a licensed provider covers you in most situations.
How It Compares to HGH Legally
The clearest way to understand sermorelin’s legal status is to compare it with human growth hormone. HGH is not a traditional controlled substance either, but it has its own federal restrictions under the Anti-Drug Abuse Act of 1988. Distributing HGH for any purpose not approved by the FDA is a felony. Sermorelin carries no equivalent criminal statute. You can legally receive a prescription for sermorelin for off-label uses like anti-aging or body composition goals without the legal complications that surround HGH.
That said, “not controlled” doesn’t mean “unregulated.” Sermorelin is still a prescription drug, compounding pharmacies are still subject to state and federal oversight, and using it without medical supervision carries real health risks. Growth hormone secretagogues as a class have been associated with side effects including cardiovascular issues and, with long-term misuse, a condition called acromegaly where tissues and bones enlarge abnormally.